Device for liposuction comprising: a cannula means; a movement means configured to cause a translational oscillation movement of the cannula means in a movement direction of the cannula means with a frequency smaller than 100 Hz, wherein the movement means is an electro-magnetic actuator configured to cause the translational oscillation movement of the cannula means electro-magnetically, wherein the device comprises a fixed portion and a movable portion, wherein the cannula means is part of the movable portion, wherein the movable portion is supported by the fixed portion movably in the movement direction of the cannula means, wherein the movement means comprises a first magnetic means in the fixed portion and a second magnetic means in the movable portion or connected to the movable portion, wherein one of the first and second magnetic means is an electro-magnetic means powered by electrical power and causing a magnetic field which interacts with the other of the first and second magnetic means to cause the translational oscillation movement of the movable portion and/or the cannula means.

Preparation of a product comprising stromal vascular traction cells includes washing human biological material comprising adipose in a container apparatus having an internal filter, which divides an internal containment volume of the container apparatus into a tissue retention volume on one side of the filter and a filtrate volume on an opposite side of the filter, and a mixing device with at least one rotatable mixing member disposed in the tissue retention volume. The washing includes operation of the mixing device to rotate the mixing member through the human biological material within the tissue retention volume, and the washing is followed by digesting washed material within the internal containment volume with added enzyme, centrifuging of the container apparatus to prepare a centrifuged pellet in the filtrate volume, selectively removing material of the pellet and preparing a product with a mixture of stromal vascular fraction cells of removed pellet material and an aqueous suspension liquid.

The invention is a medical treatment mechanism. Using an organic material which is ignited and inhaled by a patient, such as tobacco or cannabis, a breakable capsule containing the medicine is contained and selectively released so that heat from the ignited organic material activates the medicine. The medicine is released, ideally by the patient breaking the capsule, the medicine is inhaled by the patient for treatment of a medical condition.

The METHODS, APPARATUSES AND SYSTEMS FOR INSTILLING STEM CELLS AND PHARMACEUTICALS INTO THE HUMAN VENTRICULAR SYSTEM (hereinafter “Ventricular Stem Cell System” or “VSCS”) disclosed herein provide safe and effective techniques for obtaining stem cells and instilling any type of stem cell or pharmaceutical agents into the human ventricular system for treatment of various diseases, including neurodegenerative diseases such as Parkinson's, Alzheimer's, Multiple Sclerosis, and others.

A syringe for withdrawing an aspirate from a body for micro fat grafting is provided. The syringe includes a barrel having an inner wall extending therein. The inner wall has one or more apertures formed therein allowing the aspirate to contact an absorbent positioned between the inner wall and an outer wall of the barrel. A plunger moves longitudinally within the barrel along the inner wall and has a gasket attached to a proximal end forming a seal against the inner wall. The absorbent may take many forms to absorb a non-fat cell portion of the aspirate. A related method includes retracting the plunger from a first position to draw the aspirate from a harvest site of a body into the barrel, exposing the aspirate to the absorbent, and moving the plunger toward the first position so a remaining portion of the aspirate is no longer exposed to the absorbent.

Methods of treating a medical condition in a patient include performing a lipectomy of visceral fat to remove a quantity of the visceral fat from the subject. The removal of visceral fat treats the medical condition such that the subject experiences at least a reduction of symptoms of the medical condition.

Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.

A triple-chambered container includes: a main container body with a first chamber which has an opening at its distal end; a main barrel formed and movable longitudinally within the first chamber, the main barrel defining therein a second chamber for receiving fluids, the main barrel further having an apertured stopper at its distal end; a second barrel formed within the main barrel, the second barrel defining a third chamber for receiving fluids, the second barrel being movable longitudinally within and with respect to the main barrel, the second barrel having a distal end which is engageable and disengageable with the apertured stopper; a shaft adapted to fit within the second barrel, the shaft being movable longitudinally within and with respect to the second barrel, the shaft having a distal end which is engageable and disengageable with an aperture in the second barrel; a device for controlling engaging and disengaging of the distal end of the shaft with the aperture of the second barrel. The first chamber, the second chamber and the third chamber may be selectively moved to receive and discharge fluids with respect to one another.

A system comprising a handpiece and drive system configured to removably couple to a proximal end of a housing. A scalpet assembly is configured to removeably couple to the housing, and includes a scalpet array comprising at least one scalpet configured for rotation. The scalpet array is configured to harvest dermal plugs via fractional resection. A collection chamber is configured to collect the dermal plugs, and to house formation of an injectable filler by mincing the dermal plugs, and mixing the dermal plugs with a carrier. The injectable filler is configured for bulk fill. The collection chamber includes a loading port, and a cannular syringe is configured to mate with the loading port to receive the injectable filler, and to deliver the injectable filler for the bulk fill.

A method for skin ligament injection incorporates the benefits of regenerative medicine to provide more natural and longer lasting results in the revitalization of a patient's face. The method includes a first phase in which through the use of aspiration tubes with reduced diameter, small aspiration holes and controlled aspiration pressure with aspiration in a superficial plane of the skin, a user collects tissue rich in stein cells with waste of fibrotic tissue. A second phase includes the sterile manipulation and washing of fat to collect only the tissue containing the stein cells arranged around vascular structures and growth factors collected inside organelles called exosomes. Lastly, a third and final phase includes injecting the obtained product into the skin of a patient.